Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. Diabetes Research and Clinical Practice. 2012.
Effects of Fibrates in Kidney Disease: A Systematic Review and Meta-Analysis. Journal of the American College of Cardiology. 2012.
Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial. In: 21st European Stroke Conference. 21st European Stroke Conference. Lisbon, Portugal; 2012.
Global randomized trials: the promise of India and China. Journal of Bone and Joint Surgery. American Volume. 2012;94 Suppl 1:92-6..
Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study. Diabetes Care. 2012.
Managing diabetes and associated risk factors for ischemic heart disease (Clinical Seminar) [Invited speaker]. In: World Congress of Cardiology. World Congress of Cardiology. Dubai, United Arab Emirates; 2012..
Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance. International Journal of Pharmacy Practice. 2012;20:155-63..
(Plenary speaker) Cardiovascular disease prevention – Should we intervene earlier?. In: 1st International 4 Corners or Cardiology Meeting. 1st International 4 Corners or Cardiology Meeting. Melbourne, Australia; 2012..
Polypill in the prevention of cardiovascular disease: rationale and clinical data. Clinical Investigation. 2012;2:1213–1229..
Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes. American Journal of Kidney Diseases. 2012;60:9.
Research in low-resources settings. In: International Society of Hypertension Scientific Sessions. International Society of Hypertension Scientific Sessions. Sydney, Australia; 2012..
Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia. 2012;55:1283-90.
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. Journal of the American Heart Association. 2012.
Socio-economic distribution of cardiovascular risk factors and knowledge in rural India. International Journal of Epidemiology. 2012;41:1302-14.
Study protocol: systematic review of the burden of heart failure in low- and middle-income countries. Cochrane Database of Systematic Reviews. 2012;1:59.
The Treatment of cardiovascular Risk in Primary care using Electronic Decision supOrt (TORPEDO) study-intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention i. BMJ Open. 2012;2.
Two decades of research on innovative models of care delivery for patients with heart failure: the end or just the beginning?. Archives of Iranian Medicine. 2012;15:439-45..
Use of a multidrug pill in reducing cardiovascular events (UMPIRE): a rationale and design of a randomised control trial of a cardiovascular preventive polypill-based strategy in India and Europe. European Journal of Preventive Cardiology. 2012.
Women's cardiovascular health in India. Heart. 2012;98:456-9..
A Hospital Quality Improvement Initiative for Patients with Acute Coronary Syndromes in China: A Cluster Randomised Controlled Trial. CSANZ. 2011;20:S200.
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS ONE. 2011;6:e19857.
Barriers to research (breakfast session). In: Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth, Australia; 2011..
Clinical Trials in Asia – Crouching Tiger, Hidden Dragon (keynote plenary – Curtis Meinert Lecture). In: Society of Clinical Trials Annual Scientific Meeting. Society of Clinical Trials Annual Scientific Meeting. Vancouver, Canada; 2011..
Collaborations to enhance chronic disease research capacity. In: India Forum, University of Sydney. India Forum, University of Sydney. Sydney, Australia; 2011..
Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetes. Medical Care. 2011;49:962-70.